Oral CBP-0276 for Active Psoriatic Arthritis – a Clinical Trial
Part of Bones, joints & muscles, Skin clinical trials.
This study tests an oral medication called CBP-0276 for people with active psoriatic arthritis. It compares the new drug to a placebo to see if it helps reduce joint pain and skin symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have had psoriatic arthritis symptoms for 6 to 12 months.
- You have at least 3 tender or swollen joints and a history of plaque psoriasis (or current psoriasis patches).
- You have tried NSAIDs or standard DMARDs (like methotrexate) and they didn't help enough or caused side effects.
- You have not used certain other treatments recently, like biologics or JAK inhibitors, or have not had certain infections or health conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medication, CBP-0276, to see if it improves psoriasis symptoms and quality of life. It is for people with moderate to severe plaque psoriasis who might need stronger treatment.
This study tests an experimental drug called JNJ-88545223 to see if it can reduce joint pain, swelling, and skin plaques in people with active psoriatic arthritis. It may help if you have both joint symptoms and psoriasis.
This trial tests an oral medication, D-2570, for people with active psoriatic arthritis. It aims to see if the drug can reduce joint pain and swelling.
This trial tests a new capsule, TQH3906, for people with active psoriatic arthritis who haven't had success with other treatments. It aims to see if the drug is safe and works well for joint and skin symptoms.
This trial tests a new oral medicine (HS-10374) for people with active psoriatic arthritis who have not responded well to standard treatments. It compares the drug to a placebo to see if it reduces joint pain, swelling, and skin symptoms.
This study looks at how people with psoriatic arthritis respond to different types of biologic or targeted synthetic drugs. Participants will be starting a new treatment, and the study will check both clinical symptoms and immune system changes over time.
Hear when a new Arthritic Psoriasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.